Continue to opt for HDT/ASCT for multiple myelomaJanuary 5, 2018Multiple MyelomaHematologic Malignancies
Higher Risk of Secondary Cancers for Patients With Mycosis FungoidesDecember 14, 2017Hematologic Malignancies
Late-breaking abstracts highlight treatment advances in CLL, myeloma, and moreNovember 22, 2017Hematologic MalignanciesMultiple Myeloma
FDA approves first gene therapy – tisagenlecleucel for ALLAugust 30, 2017Hematologic MalignanciesImmuno-oncology
The Challenges of Precision Medicine and New Advances in Molecular Diagnostic Testing in Hematolymphoid Malignancies: Impact on the VHA (FULL)August 4, 2017Hematologic MalignanciesImmuno-oncology
Which Acute Myeloid Leukemia Patients are Good Immunotherapy Candidates?August 1, 2017Hematologic Malignancies
Evaluation of Fitness, Metabolism, and Quality of Life During Hematopoietic Stem Cell TransplantAugust 1, 2017Hematologic Malignancies